In this Review Joshua J. Meeks discusses advancements in biomarkers and novel therapeutics that are likely to dramatically improve survival of patients with Bladder Cancer.
1Departments of Urology and.
2Biochemistry and Molecular Genetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
3Jesse Brown VA Medical Center, Department of Veterans Affairs, Chicago, Illinois, USA.
Address correspondence to: Joshua J. Meeks, Department of Urology, Biochemistry and Molecular Genetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA. Phone: 312.695.8146; Email: [email protected].